Max Robotics — Global Service Robot Directory + US Certification

About

The European Institute of Oncology (IEO) in Milan stands as one of Europe's foremost cancer research and treatment centers, distinguished by its seamless integration of clinical excellence, translational research, and pioneering surgical innovation. Founded on the vision of Professor Umberto Veronesi, IEO has established itself as a global benchmark for comprehensive oncological care, consistently advancing the boundaries of cancer diagnosis, treatment, and patient outcomes. IEO's research portfolio reflects a remarkable dual strength: the development of internationally authoritative clinical guidelines and the bold adoption of robotic surgical technologies. The institute has been a primary contributor to ESMO Clinical Practice Guidelines for gynecological cancers—including cervical, endometrial, and ovarian malignancies—with landmark publications accumulating over 2,500 citations combined, shaping oncological practice across continents. These guidelines serve as essential references for clinicians worldwide, underscoring IEO's role in standardizing and elevating cancer care globally. Equally impressive is IEO's leadership in robotic and minimally invasive surgery. The institute has produced seminal work on robotic-assisted radical prostatectomy, robotic lobectomy for lung cancer, robotic total mesorectal excision for rectal cancer, and the groundbreaking development of robotic nipple-sparing mastectomy—a technique pioneered at IEO that has transformed breast cancer surgery. These contributions, collectively drawing hundreds of citations, have validated robotic approaches as safe and effective alternatives across multiple cancer types. IEO also holds distinction in intraoperative radiotherapy for breast cancer, with early studies that helped establish IORT as a viable treatment modality. For prospective students, clinicians, and research collaborators, IEO offers an intellectually vibrant environment where surgical innovation, clinical research, and compassionate oncological care converge at the highest international level.